Short Interest in POXEL FRANCE (OTCMKTS:PXXLF) Increases By 26,900.0%

POXEL FRANCE (OTCMKTS:PXXLFGet Free Report) was the recipient of a large growth in short interest in the month of July. As of July 31st, there was short interest totaling 27,000 shares, agrowthof26,900.0% from the July 15th total of 100 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

POXEL FRANCE Stock Performance

Shares of PXXLF opened at $0.25 on Friday. The company’s fifty day moving average price is $0.25 and its 200 day moving average price is $0.25. POXEL FRANCE has a one year low of $0.25 and a one year high of $0.25.

About POXEL FRANCE

(Get Free Report)

Poxel SA, a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan.

Further Reading

Receive News & Ratings for POXEL FRANCE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for POXEL FRANCE and related companies with MarketBeat.com's FREE daily email newsletter.